Peterlin B, Zidar J, Meznaric-Petrusa M, Zupancic N
Department of Obstetrics and Gynaecology, University Medical Centre Ljubljana, Slovenia.
Clin Genet. 1997 Feb;51(2):94-7. doi: 10.1111/j.1399-0004.1997.tb02427.x.
Most population studies on Duchenne (DMD) and Becker (BMD) muscular dystrophies predated the discovery of the gene and its product dystrophin. The diagnosis of these conditions and consequent epidemiological estimates were therefore limited to clinical criteria. In our study of the Slovene population the prevalence and cumulative incidence of DMD and BMD were calculated by including additional diagnostic tests: deletion screening in the dystrophin gene as well as dystrophin immunocytochemistry. The minimal prevalence rates, 2.9/100,000 for DMD, 1.2/100,000 for BMD, and the minimal cumulative DMD incidence rate of 13.8/100,000 are in the range of lower estimates compared to studies world-wide. However, we found a high BMD cumulative incidence rate of 5.7/100,000 and a high proportion of BMD versus DMD cumulative incidence rate (41.3%). Our results imply that the epidemiological figures for BMD might have been underestimated in the past.
大多数关于杜氏肌营养不良症(DMD)和贝克肌营养不良症(BMD)的人群研究都早于该基因及其产物抗肌萎缩蛋白的发现。因此,这些疾病的诊断以及由此得出的流行病学估计仅限于临床标准。在我们对斯洛文尼亚人群的研究中,通过纳入额外的诊断测试来计算DMD和BMD的患病率和累积发病率:抗肌萎缩蛋白基因的缺失筛查以及抗肌萎缩蛋白免疫细胞化学检测。与全球范围内的研究相比,DMD的最低患病率为2.9/100,000,BMD为1.2/100,000,DMD的最低累积发病率为13.8/100,000,均处于较低估计范围。然而,我们发现BMD的累积发病率较高,为5.7/100,000,且BMD与DMD累积发病率的比例较高(41.3%)。我们的结果表明,过去BMD的流行病学数据可能被低估了。